Vimarsana
Biggest News Aggregation in the World

Danielj Speciale News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Danielj Speciale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Danielj Speciale Today - Breaking & Trending Today

Mallinckrodt Announces FDA Clearance of the INOmax® EVOLVE™ DS Delivery System and Approval of the INOmax® (nitric oxide) Mini-Cylinder - Vimarsana News

Mallinckrodt Announces FDA Clearance of the INOmax® EVOLVE™ DS Delivery System and Approval of the INOmax® (nitric oxide) Mini-Cylinder

Published: December 7, 2023

/PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced that the INOmax® EVOLVE™ DS delivery system has been cleared by...

Source: prnewswire.com
Related Topics:
United KingdomDerek BelzDanielj SpecialePrnewswire MallinckrodtGreen Room CommunicationsDrug AdministrationErgonomics SocietyMallinckrodt PharmaceuticalsHuman FactorsDevice WarningsImportant Safety InformationExecutive Vice PresidentChief Scientific OfficerStanley Caplan User Centered Product DesignAdam ShamesNitric OxideFull PrescribingSpecialty BrandsSpecialty GenericsAnnual ReportVice PresidentChief Financial OfficerMallinckrodt Plc
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2023 Scientific Meeting - Vimarsana News

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2023 Scientific Meeting

Published: November 1, 2023

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, today announced that three scientific abstracts evaluating...

Source: prnewswire.com
Related Topics:
United StatesJuan Carlosq VelezPrnewswire MallinckrodtDerek BelzHanim WadeiJamilk TerlipressinDanielj SpecialeKhurram JamilMallinckrodt Hospital Products IncOchsner HealthGreen Room CommunicationsNational Organization For Rare DisordersMallinckrodt PharmaceuticalsExchange CommissionClinical Development Critical CareAmerican Society Of NephrologyPennsylvania Convention CenterAmerican SocietyKidney WeekImportant Safety InformationBoxed WarningJuan CarlosVice PresidentClinical DevelopmentSerum Creatinine
Mallinckrodt Presents Latest Health Economics Data on Acthar® Gel (Repository Corticotropin Injection) at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 - Vimarsana News

Mallinckrodt Presents Latest Health Economics Data on Acthar® Gel (Repository Corticotropin Injection) at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Published: October 26, 2023

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, recently shared findings from Mallinckrodt's latest health...

Source: prnewswire.com
Related Topics:
United StatesDanielj SpecialePrnewswire MallinckrodtDerek BelzDrug AdministrationAmerican College Of Chest PhysiciansSymphony HealthOutcomes Research OnMallinckrodt PharmaceuticalsAcademy Of Managed Care PharmacyNational Institute Of HealthGreen Room CommunicationsData SciencesExchange CommissionNational Institute Of DiabetesNephcure Kidney InternationalActhar GelManaged Care PharmacyImportant Safety InformationAdvanced Symptomatic SarcoidosisOutcomes ResearchPatient CharacteristicsTreatment PatternsRelated Outcomes After TreatmentComparable Standard
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American College of Gastroenterology (ACG) Annual Scientific Meeting - Vimarsana News

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American College of Gastroenterology (ACG) Annual Scientific Meeting

Published: October 22, 2023

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, today announced that three posters detailing findings from...

Source: prnewswire.com
Related Topics:
United StatesBritish ColumbiaUnited KingdomPalo AltoRonaldj WongJacquelineg OlearyDerek BelzRobertj WongPrnewswire MallinckrodtPaulj ThuluvathRyan TaylorDanielj SpecialeKhurram JamilPrashant PandyaMallinckrodt PharmaceuticalsStanford University School Of MedicineGreen Room CommunicationsNational Organization For Rare DisordersClinical Development Critical CareMallinckrodt Hospital Products IncAmerican College Of GastroenterologyExchange CommissionUnited States Census BureauAmerican CollegeAnnual Scientific Meeting
Mallinckrodt Announces Publication of Two Journal Manuscripts with Clinical and Economic Evidence for Acthar® Gel (Repository Corticotropin Injection) - Vimarsana News

Mallinckrodt Announces Publication of Two Journal Manuscripts with Clinical and Economic Evidence for Acthar® Gel (Repository Corticotropin Injection)

Published: October 10, 2023

/PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, today announced the publication of two journal manuscripts...

Source: prnewswire.com
Related Topics:
United StatesPrnewswire MallinckrodtDerek BelzJeffrey KaplanHayesk ActharLiq ImmunopathologyDanielj SpecialeDrug AdministrationMyositis AssociationArthritis FoundationRheumatology CenterMallinckrodt PharmaceuticalsOutcomes ResearchCenters For DiseaseSclerosis SocietyGreen Room CommunicationsNational Resource Center On LupusNational Multiple Sclerosis SocietyData SciencesNational Institute Of DiabetesVeterans Affairs Medical CentersNephcure Kidney InternationalExchange CommissionAmerican College Of Chest PhysiciansNational Institute Of Health